Results of a phase II trial of the GliaSite Radiation Therapy System for the treatment of newly diagnosed, resected single brain metastases
Lisa R. Rogers(University of Michigan), Edward G. Shaw(Wake Forest University), Paul D. Lewis, Anthony Asher, Judith S. Billingsley, John H. Suh(Cleveland Clinic), Dawid Schellingerhout, Jack Rock, Robert W. Fraser, Michael A. Vogelbaum, Allen K. Sills(NFL Foundation), Thomas L. Ellis(Wake Forest University), Volker W. Stieber(Southeast Clinical Oncology Research Consortium)
Cited by 102
Related Papers
Consensus statement on concussion in sport—the 5<sup>th</sup> international conference on concussion in sport held in Berlin, October 2016
|British Journal of Sports Medicine|2017|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k